Competitive bioreactor hens on the horizon
- PMID: 16445998
- DOI: 10.1016/j.tibtech.2006.01.004
Competitive bioreactor hens on the horizon
Abstract
The hen has long held promise as a low-cost, high-yield bioreactor for the production of human biopharmaceuticals in egg whites using genetic engineering. Two separate reports have recently appeared indicating the production of substantial levels of human monoclonal and single chain antibodies (>3 mg and >150 mg, respectively) in eggs of transgenic hens. These promising findings indicate that the hen is close to becoming a competitive manufacturing platform for the production of human biopharmaceuticals.
Comment in
-
Response to Ivarie: Competitive bioreactor hens on the horizon.Trends Biotechnol. 2006 Mar;24(3):101-2. doi: 10.1016/j.tibtech.2006.01.003. Epub 2006 Jan 30. Trends Biotechnol. 2006. PMID: 16448712 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
